- Home
- DIN vs NGNE Comparison
DIN vs NGNE Comparison
Compare DIN & NGNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DIN
- NGNE
- Stock Information
- Founded
- DIN 1958
- NGNE 2003
- Country
- DIN United States
- NGNE United States
- Employees
- DIN N/A
- NGNE N/A
- Industry
- DIN Restaurants
- NGNE Biotechnology: Pharmaceutical Preparations
- Sector
- DIN Consumer Discretionary
- NGNE Health Care
- Exchange
- DIN Nasdaq
- NGNE Nasdaq
- Market Cap
- DIN 379.1M
- NGNE 325.3M
- IPO Year
- DIN 1991
- NGNE N/A
- Fundamental
- Price
- DIN $24.35
- NGNE $18.68
- Analyst Decision
- DIN Hold
- NGNE Strong Buy
- Analyst Count
- DIN 9
- NGNE 7
- Target Price
- DIN $26.57
- NGNE $41.86
- AVG Volume (30 Days)
- DIN 543.2K
- NGNE 137.0K
- Earning Date
- DIN 11-05-2025
- NGNE 11-14-2025
- Dividend Yield
- DIN 8.38%
- NGNE N/A
- EPS Growth
- DIN N/A
- NGNE N/A
- EPS
- DIN 2.99
- NGNE N/A
- Revenue
- DIN $845,368,000.00
- NGNE N/A
- Revenue This Year
- DIN $11.28
- NGNE N/A
- Revenue Next Year
- DIN $2.11
- NGNE N/A
- P/E Ratio
- DIN $8.15
- NGNE N/A
- Revenue Growth
- DIN 2.92
- NGNE N/A
- 52 Week Low
- DIN $18.63
- NGNE $6.88
- 52 Week High
- DIN $37.44
- NGNE $74.49
- Technical
- Relative Strength Index (RSI)
- DIN 59.44
- NGNE 45.88
- Support Level
- DIN $23.58
- NGNE $17.13
- Resistance Level
- DIN $24.96
- NGNE $20.72
- Average True Range (ATR)
- DIN 0.82
- NGNE 1.28
- MACD
- DIN 0.14
- NGNE -0.11
- Stochastic Oscillator
- DIN 75.30
- NGNE 43.21
About DIN Dine Brands Global Inc.
Dine Brands Global Inc owns and franchises thousands of restaurants under the Applebee's and International House of Pancakes names. Almost all company restaurants are located in the United States and franchised. Royalty revenue, which the company gets from franchisees based on franchisees' sales, accounts for roughly three-quarters of total company revenue. The company also earns revenue by leasing restaurant sites to franchisees. The company has four reportable segments Franchise operations, (an aggregation of Applebee's and IHOP franchise operations), Rental operations, Financing operations and Company-operated restaurant operations. The majority of revenue is derived from the Franchise operations segment.
About NGNE Neurogene Inc.
Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACTTM (Expression Attenuation via Construct Tuning). It is building a differentiated product portfolio of genetic medicines for rare neurological diseases with high unmet needs. The drug candidates in the company's product pipeline include NGN-401, which is in development for the treatment of Rett syndrome, using its EXACT platform, and NGN-101, a non-EXACT, conventional gene therapy development candidate for the treatment of CLN5 Batten disease, designed to deliver the CLN5 gene and packaged in an AAV9 capsid.